Skip to main content
Verified by IngredientMD/Needed/Prenatal Multi
VERIFIED BYingredientMD

Prenatal Multi.

Strong evidence, strong doseNeeded, verified Oct 2026Formula verified. Independently reviewed.Independent review. Not commissioned by Needed.

Choline is the lead active here, studied most for choline status. 10 human studies on Choline back this formula, each one cited. Each serving carries 800 mcg of Folate, inside the range the published research used. Who it fits: made for women, adults.

Clinically dosedFull label disclosure
10Active ingredientsWell studiedResearch base107Human studies
Prenatal MultiVerified by IngredientMD
NeededIngredientMD
The verdict
Strong evidence, strong dose
For Made for women, adults.
How we verify

The brand submits the formula. We read the supplement facts panel and weigh dose, form and synergy against the clinical evidence. Labs test. IngredientMD verifies. The fee pays for review time, never for the outcome.

The formula
Folate: MethylationExtensively studied
Iron: Iron statusExtensively studied
Choline: Choline statusKey driver
Vitamin D3: Vitamin D statusExtensively studied
Vitamin K2: Filling everyday nutrient gapsSupporting role
Iodine: Iodine statusExtensively studied
Zinc: Filling everyday nutrient gapsExtensively studied
Vitamin B12: MethylationExtensively studied
Magnesium: Magnesium statusExtensively studied
Selenium: Filling everyday nutrient gapsSupporting role

How we read this product

Source: Supplement facts
Supplement Facts panel for Prenatal Multi
  1. 01
    We read the label.

    The panel on the left is the one we evaluated, line by line.

  2. 02
    Every active, separately.

    All 10 actives checked against the clinical evidence: dose, form, and what the research actually shows.

  3. 03
    Then the formula as a whole.

    Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Strong evidence, strong dose".

  4. 04
    Earned, not bought.

    The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.

Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.

The receipts

Well studied
Research base
107
Human studies
300 mg
Choline
800 mcg
Folate
800 mcg per serving sits inside the studied 400 mcg-800 mcg range
Folate, NIH ODS + Bailey 2015 review
18 mg per serving sits inside the studied 18 mg-27 mg range
Iron, NIH ODS + WHO guidelines
300 mg per serving sits inside the studied 250 mg-550 mg range
Choline, NIH ODS + Zeisel 2006 + IOM 1998
290 mcg per serving clears the studied 150 mcg minimum
Iodine, NIH ODS + Zimmermann 2009 review

Cross-checked against 1,787 documented interactions for these actives.

Read the evidenceFolate, the evidence →Iron, the evidence →Choline, the evidence →Vitamin D3, the evidence →Vitamin K2, the evidence →Iodine, the evidence →

Inside the formula

Folate
12 studies
Methylation
Studied 400 mcg to 1 mg a day
Extensively studied
Iron
Iron status
Extensively studied
Choline
10 studies
Choline status
Studied 250 mg to 1 g a day
Key driver
Vitamin D3
17 studies
Vitamin D status
Extensively studied
Vitamin K2
Filling everyday nutrient gaps
Supporting role
Iodine
Iodine status
Extensively studied
Zinc
22 studies
Filling everyday nutrient gaps
Studied 8 mg to 30 mg a day
Extensively studied
Vitamin B12
11 studies
Methylation
Extensively studied
Magnesium
15 studies
Magnesium status
Extensively studied
Selenium
Filling everyday nutrient gaps
Supporting role
In context

The gap this formula speaks to.

Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.

52 more
Folate

Systematic review, 2026

Across 22 studies, starting folic acid near conception linked most consistently to better later cognitive and language development in children, an association, not a cause, too varied to pool.

Frontiers in Neuroscience
Zinc

Meta-analysis, 2025

Across 77 trials, zinc alone in healthy pregnancy raised blood zinc and was linked to better birth measures, though adding it to iron and folate added nothing extra.

Journal of Evidence-Based Medicine
Choline

Meta-analysis, 2025

In children of pregnancies with heavy alcohol exposure, choline in pregnancy was linked to higher memory scores (moderate confidence), and after birth to better overall thinking (lower confidence).

Pediatrics and Neonatology
Zinc

Meta-analysis, 2024

Across six trials in 739 women, zinc lowered menstrual discomfort scores, with bigger drops after eight weeks or more, even at doses as low as 7 mg daily.

Nutrients
Folate

Randomised trial, 2007

In 818 adults aged 50 to 70 with raised homocysteine, 3 years of daily folic acid at 800 micrograms improved memory and information-processing speed scores compared with placebo.

The Lancet
Vitamin K2

Cohort study, 2025

Habitual natto intake was associated with higher serum MK-7, greater osteocalcin carboxylation and higher measured bone density.

Frontiers in Nutrition
Selenium

Meta-analysis, 2025

Across pooled trials, taking selenium was linked to lower thyroid antibody levels in the blood, though results varied across trials and forms of selenium.

Medicine
Selenium

Randomised trial, 2025

Selenomethionine-enriched yeast was assessed in adults with underactive thyroid function, with the authors reporting changes in thyroid-related laboratory measures.

Archives of Razi Institute
Folate

Systematic review and meta-analysis, 2023

Across 21 trials in 2,025 adults, folic acid improved flow-mediated dilation, a measure of how well arteries widen, by about 2.6 percentage points.

Nutrition Journal
Iodine

Systematic review and meta-analysis, 2020

In pregnant women with mild to moderate iodine deficiency, iodine lowered a thyroid marker and curbed the usual pregnancy rise in thyroid size. Infant cognitive, language and motor scores showed no change across trials.

American Journal of Clinical Nutrition
Vitamin D3

Meta-analysis, 2026

Across 11 trials in 992 women of reproductive age, vitamin D produced no detectable change in a blood hormone marker of ovarian reserve.

Frontiers in Endocrinology
Iodine

Meta-analysis, 2026

In pregnant women with low iodine status, iodine was linked to lower TSH and thyroglobulin in the blood, both markers rather than health outcomes.

Frontiers in Public Health
Vitamin D3

Meta-analysis, 2026

A review of vitamin D supplementation and semen quality measures in men found effects on sperm markers, not proven reproductive outcomes.

PeerJ
Vitamin B12

Randomised trial, 2026

Two oral B12 doses were compared for nerve-related outcomes, but the report only describes the difference between them, not which dose is better.

The Journal of nutrition
Vitamin B12

Systematic review, 2025

Across 16 studies in 6,098 people, vitamin B12 raised blood B12 levels by about 403 pg/mL, with oral or under-the-tongue doses working about as well as injections.

Frontiers in pharmacology
Vitamin D3

Meta-analysis, 2021

Across trials in older adults, vitamin D alone showed no detectable change in fall risk, while vitamin D with calcium was linked to fewer falls, mainly in those starting with low vitamin D levels.

Clinical Nutrition
Vitamin D3

Meta-analysis, 2012

In head to head randomised trials, vitamin D3 raised blood 25-hydroxyvitamin D more than vitamin D2, with the gap clearest after a single large dose and less apparent with daily dosing.

The American Journal of Clinical Nutrition
Iron

Meta-analysis, 2023

Across 17 randomised trials, at least 4 weeks of ferrous bisglycinate raised haemoglobin in pregnant women more than other iron supplements (standardised mean difference 0.54) and was linked to fewer reported stomach and gut complaints (incidence rate ratio 0.36), while no difference was detected in children.

Nutrition Reviews
Iron

Randomised trial, 2018

In a small pilot randomised comparison in children with low iron stores, iron bisglycinate chelate raised haemoglobin and ferritin at a lower elemental iron dose than iron polymaltose, with the pilot too small to establish that the two are equivalent.

Current pediatric reviews
Folate

About 23 percent lower plasma homocysteine at 0.8 mg daily, with 0.2 mg and 0.4 mg reaching roughly 60 and 90 percent of that

Lowers homocysteine, a blood marker tied to heart risk. Measured in adults, standardised to a pretreatment homocysteine of 12 micromol per litre (95% CI 21 to 26 percent).

Meta-analysis
Vitamin K2

Meta-analysis, 2025

Pooled trials of MK-7 supplementation examined body measurements, blood sugar indices and blood lipids, with effects that were small and inconsistent across studies.

Prostaglandins Other Lipid Mediat
Vitamin B12

Randomised trial, 2024

Adults taking methylfolate, pyridoxal-5'-phosphate and methylcobalamin together lowered circulating homocysteine compared with placebo.

Nutrients
Vitamin K2

Randomised trial, 2026

Reported that effects of MK-7 supplementation on body composition and adiposity markers differed between men and women.

Nutrients
Vitamin B12

Systematic review, 2025

A review summarizes reported immune-related changes when B12 levels are restored in adults with impaired absorption, noting the evidence base is small and doesn't test this specific form on its own.

Oxidative medicine and cellular longevity
Iron

Randomised trial, 2025

In a head to head absorption comparison, a glycoprotein matrix bound iron produced a larger rise in serum iron than ferrous bisglycinate chelate or ferrous fumarate.

Cureus
Choline

Randomised trial, 2018

Infants whose mothers took 930 mg of choline daily in the third trimester had significantly faster reaction times on processing tasks over the first year than the lower-dose group.

FASEB Journal
Choline

Randomised trial, 2022

In a seven-year follow-up, children whose mothers took 930 mg of choline daily in the third trimester scored higher on a sustained-attention task than the lower-dose group.

FASEB Journal
Zinc

Meta-analysis, 2011

Across 36 studies in children under five, zinc modestly increased height growth, adding roughly 0.37 cm at about 10 mg a day for 24 weeks.

BMC Public Health
Iodine

Systematic review, 2026

A Cochrane review of eight trials in children and adolescents found iodine supplements gave a slight rise in cognitive test scores over placebo, a standardised difference of 0.19 in one trial of 166 participants.

The Cochrane database of systematic reviews
Vitamin K2

Cohort study, 2026

Described longitudinal height growth patterns in children receiving menaquinone-7 supplementation.

Nutrients
Choline

Systematic review, 2025

Across eight studies, about 40 to 50 mg per kg daily of oral choline kept blood choline in preterm infants near cord blood level, while IV dosing remains unsettled.

Revista Paulista de Pediatria
Iron

Randomised trial, 2022

In young children, iron chelate absorption from oat cereal was about 7.4%, similar to iron salt, lower than other cereals.

The Journal of Nutrition
Vitamin D3

Meta-analysis, 2026

Pooling trials in adult men, vitamin D supplementation showed no consistent change in total testosterone or androgen availability markers.

Nutrients
Choline

Randomised trial, 2005

Two weeks of choline taken as phosphatidylcholine (about 2.6 g choline a day) lowered fasting plasma homocysteine by 18 percent, roughly 3.0 micromol/L, versus placebo in healthy men with mildly raised levels.

American Journal of Clinical Nutrition

Population figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.

What this formula earned

Every one of these is a fact the engine could ground.

Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.

  • Studied in people22 human studies on Zinc back this formula, each one cited.
  • A mechanism that is settledHow Folate and Iron work is settled pharmacology.
  • Studied together, not just separatelyFolate and Choline have been studied together, not only separately.
  • Recent work on the recordThe most recent study on this record was published in 2024.
  • Serving amount inside the studied rangeEach serving carries 800 mcg of Folate, inside the range the published research used.
  • A stated daily maintenance amountFolate is here at a daily maintenance amount, which is what a daily supplement is for.
  • Why this formatIt is a capsule, so the amount per serving is fixed and travels without measuring.
  • The exact form, describedThe label names its forms exactly: Folinic acid, Iron bisglycinate (Ferrochel), Choline bitartrate. The record says what each one is and what it suits.
  • Full label disclosureEvery ingredient on this label carries its own declared amount.
  • Where it comes from and how it is madeFolate is made by more than one route.
  • Positions this formula already qualifies forThis formula already qualifies for positions beyond the one it is sold into, on the evidence it carries.
  • A position nobody is holding yetSome of those positions are ones almost nobody is selling to yet.
  • Interaction screen on the recordEvery active on this label was screened against the interaction record, and the screen is published with it.
Studied together

The combinations the trials actually measured.

One pairing in this formula has been studied as a combination in human trials. Each finding below is what a named study measured, cited and dated, never written by the brand.

  • Vitamin D3 + Vitamin K2Bone

    In a meta-analysis of eight randomized trials, vitamin K2 taken together with vitamin D raised total bone mineral density and lowered undercarboxylated osteocalcin, a marker of vitamin K status.

    Promising

Research strength. Research strength says how much work stands behind the combination. It is never a product score.

Fail closed. Where actives were studied on their own rather than together, each shows on its own evidence, never a combined effect no trial measured.

Independent record. Every finding is cited to a named trial, dated, and never written by the brand.

Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.

What the trials show

What the trials show about timing.

Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.

  • Folatea median of about 36 weeks of daily intakeBuilds with daily use

    A systematic review and Bayesian meta-analysis drew on 108 articles from 14,002 screened records and modelled blood folate against folic acid intake using one-compartment pharmacokinetic models. Red blood cell folate rose 1.78 fold from baseline to steady state at 375 to 570 ug folic acid per day, and reaching that steady state took a median of 36 weeks, 95% credible interval 27 to 52 weeks. Serum or plasma folate rose 11.6% for every 100 ug per day of folic acid intake, 95% credible interval 8.4 to 14.9.

    Strong
  • Folateabout 18 days for serum folate to reach its maximumBuilds with daily use

    A kinetic study in six healthy men aged 22 to 31 gave 3.6 umol per day, 1.6 mg, of deuterium-labelled folic acid for four weeks, with folate tracked in serum, erythrocytes and urine by microbiological assay and gas chromatography mass spectrometry. Serum folate reached its maximum concentration in about 18 days, while isotopic labelling of erythrocyte folate kept rising across the whole four weeks. After supplementation stopped, red blood cell folate and urinary folate excretion declined linearly, and serum folate fell with a slow-phase half-life of 18.7 days. One study, six men, no control group.

    Early
  • Ironwithin 24 hours of a single doseMeasured within a day

    A randomised crossover study in 54 nonanemic young women with plasma ferritin at or below 20 ug/L gave labelled iron sulfate as single fasting morning doses of 40, 60, 80, 160 and 240 mg. Twenty four hours after doses of 60 mg or more, serum hepcidin was raised and fractional iron absorption from the following dose was 35% to 45% lower. Across the dose range a sixfold rise in dose, 40 to 240 mg, produced a threefold rise in iron absorbed, 6.7 to 18.1 mg. Total iron absorbed from three doses inside 24 hours was not significantly greater than from two morning doses. The measure was iron absorption and serum hepcidin, not a symptom.

    Promising
  • Cholineabout 10 to 12 weeks of daily intakeBuilds with daily use

    In a controlled feeding study, lactating women randomised to 480 or 930 mg choline per day for 10 to 12 weeks showed that the higher intake increased breast milk choline content by raising output of endogenously synthesised choline metabolites.

    Promising
  • Vitamin D3about 3 months of daily useBuilds with daily use

    In the trial record, blood vitamin D rises for about 3 months of daily vitamin D3 and then holds at a plateau, near 69 nmol/L at 1,000 IU a day, from a starting level near 41 nmol/L.

    Early
  • Vitamin K2about four weeks of daily useBuilds with daily use

    A double-blind randomised dose-finding trial gave 60 postmenopausal women aged 50 to 69 either 0, 50, 100 or 200 micrograms of menaquinone-7 daily for four weeks on a controlled diet. The ratio of carboxylated to undercarboxylated osteocalcin rose dose dependently, with significant differences from the 0 microgram group at 100 and 200 micrograms. A companion 12-week trial in 120 people aged 20 to 69 confirmed the change at 100 micrograms daily. Both studies were run by authors affiliated with the R and D division of J-Oil Mills. An independent 8-week double-blind trial in 55 healthy prepubertal children found the same direction at 45 micrograms daily. What was measured is a blood marker of vitamin K status, not bone density and not a sensation.

    Promising
3 more
  • Vitamin K2three years of daily use, with measurements at one, two and three yearsBuilds with daily use

    A double-blind randomised trial gave 244 healthy postmenopausal women either placebo or 180 micrograms of menaquinone-7 daily for three years, with bone mineral density measured by DXA at baseline and after each year. Menaquinone-7 decreased the age-related decline in bone mineral content and bone mineral density at the lumbar spine and femoral neck, but not at the total hip. The effect is a slowed decline rather than a gain, and the trial ran three years rather than weeks.

    Promising
  • Zincover about five days of lozenges started within 24 hours of symptom onsetBuilds with daily use

    Across three randomised placebo-controlled trials pooled as individual patient data (199 adults with naturally acquired colds, 80 to 92 mg of elemental zinc a day as acetate lozenges), 70 percent of the zinc group had recovered by day 5 against 27 percent on placebo, and colds ran 2.73 days shorter against a 7 day average duration. A separate meta-analysis of seven lozenge trials (575 participants, doses above 75 mg a day, zinc acetate or zinc gluconate) measured cold duration 33 percent shorter, with no significant difference between the two salts.

    Strong
  • Zincabout two to four weeks of daily intakeBuilds with daily use

    In a controlled feeding study in nine healthy men, six weeks of restricted zinc intake raised DNA strand breaks in peripheral blood cells, and four weeks of repletion at 11 mg a day, with 20 mg of supplemental zinc for the first seven days, reversed the rise. In a separate randomised placebo-controlled trial in 40 Ethiopian women eating a high-phytate diet, 20 mg a day of zinc sulfate for 17 days lowered mean comet tail moment from 39.7 to 30.0 while plasma zinc did not change significantly. Both windows were measured on a DNA damage marker in blood cells, not on a symptom.

    Early

Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.

General timing

How each ingredient usually behaves over time.

10 ingredients, from each one's own page.

4 more

How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.

Chemical form

The same ingredient, carried differently.

What each form is, and where it fits in a formula. Measured findings carry the study that reported them.

  • Ferrous bisglycinate

    Iron chelated to two molecules of the amino acid glycine, rather than carried as a simple salt.

    Fits
    Trade-off
    at 18 mg it did not match 60 mg of ferrous sulfate for ferritin in a non-inferiority trial, and the meta-analysis found no significant difference in haemoglobin or ferritin among children
  • Potassium iodide

    The potassium salt of hydroiodic acid, a white crystalline solid that is roughly three-quarters iodide by weight and dissolves readily in water.

    Fits
    A stable, water-soluble way to supply iodide at the small microgram amounts a daily supplement calls for, which is why it is the iodine source in most multivitamins and standalone drops.
    Trade-off
    Potassium iodide is sensitive to moisture, light and air and can slowly oxidise to free iodine that yellows a tablet or liquid, so it usually needs a stabiliser and protective packaging.
  • Zinc bisglycinate

    Zinc chelated to two glycine molecules through a nitrogen and an oxygen bond, the smallest amino acid available for chelation, giving a low molecular weight chelate of about 26 percent zinc by weight. It is a neutral-tasting dry powder with mild solubility and is stable across the pH range a capsule or tablet passes through.

    Fits
    Daily capsules, tablets and blends where a chelated organic form and a neutral taste are wanted, including formulas that pair zinc with other minerals in the same dose form. The small chelate size keeps the raw weight manageable at everyday zinc targets.
    Trade-off
    The supporting human study is a pilot intervention with ten young women per arm at 60 mg zinc daily, above the 40 mg tolerable upper intake level for adults, so the reassuring copper-status reading was taken at a dose most consumer formulas do not use, over only six weeks. No stable-isotope absorption study in humans has measured this form.

    In a six-week placebo-controlled pilot intervention in young adult women (10 per arm, 30 in total) at 60 mg zinc daily, a dose above the 40 mg tolerable upper intake level for adults, plasma zinc, described by the authors as the traditional assessment of zinc status, increased in all subjects given zinc glycinate, while no significant change was seen overall for zinc gluconate or placebo. Erythrocyte superoxide dismutase activity, used in that study as a marker of zinc-induced copper deficiency, was unchanged in all three groups over the six weeks. A 2024 narrative review of the chemical forms of zinc, written by authors employed by a supplement manufacturer, states that little information is available comparing the absorption and bioavailability of the different chemical forms. No stable-isotope absorption study in humans has measured this form.

  • Methylcobalamin

    Cobalamin carrying a methyl group on the cobalt centre, the same species used directly by methionine synthase.

    Fits
    Oral tablets, capsules and powders where a preformed methylated cofactor is wanted.
    Trade-off
  • Magnesium bisglycinate

    Magnesium chelated to two molecules of the amino acid glycine, rather than carried as a mineral salt.

    Fits
    evening and sleep-positioned formulas, and pregnancy formulas aimed at leg cramps, which is where its trials sit
    Trade-off

Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.

Format

Capsule

It is a capsule, so the amount per serving is fixed and travels without measuring.

Best forMost standard doses, and anywhere a short, clean label is the point.
Recurring supply suggested

Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.

Questions shoppers ask

Is Prenatal Multi independently verified?
Yes. IngredientMD reviewed this formula independently and verified it in Oct 2026. The verdict is earned, not bought: brands can't edit or purchase it.
What's in Prenatal Multi?
Prenatal Multi is built on Folate, Iron, Choline, Vitamin D3, Vitamin K2, Iodine, and more. Each ingredient links to its own evidence page on IngredientMD.
Were ingredient interactions checked?
Yes. The combination was screened against 1,787 documented interactions for these actives in IngredientMD's interaction database.
Who is IngredientMD?
IngredientMD is an independent supplement-science platform. We analyze ingredients and formulas against clinical research, and we verify products only when they clear our bar. Labs run the tests. We review the results.
Sell a formula this good?

Put an earned verification on your own product page.

Get verified

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.

Independent review by IngredientMD, not commissioned by NeededWork at Needed? This verification is yours to claim →